Guangdong Jiaying Pharmaceutical Co., Ltd (002198.SZ)
CNY 6.47
(-0.92%)
CNY 6.47
(-0.92%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 307.2 Million CNY | -17.44% |
| 2022 | 375.96 Million CNY | -6.76% |
| 2021 | 403.22 Million CNY | 10.43% |
| 2020 | 365.15 Million CNY | -5.07% |
| 2019 | 384.64 Million CNY | 11.14% |
| 2018 | 346.08 Million CNY | 13.63% |
| 2017 | 304.57 Million CNY | 10.96% |
| 2016 | 274.48 Million CNY | 0.09% |
| 2015 | 274.22 Million CNY | 4.24% |
| 2014 | 263.06 Million CNY | 160.04% |
| 2013 | 101.16 Million CNY | 63.09% |
| 2012 | 62.02 Million CNY | 52.47% |
| 2011 | 40.68 Million CNY | 10.6% |
| 2010 | 36.78 Million CNY | 28.66% |
| 2009 | 28.59 Million CNY | 4.51% |
| 2008 | 27.35 Million CNY | 79.06% |
| 2007 | 15.27 Million CNY | 2.75% |
| 2006 | 14.86 Million CNY | 10.25% |
| 2005 | 13.48 Million CNY | 9.96% |
| 2004 | 12.26 Million CNY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q3 | 47.94 Million CNY | -3.31% |
| 2024 Q1 | 45.84 Million CNY | -43.07% |
| 2024 Q2 | 51.13 Million CNY | 11.54% |
| 2023 Q4 | 80.51 Million CNY | 2.73% |
| 2023 Q1 | 70.64 Million CNY | -38.28% |
| 2023 FY | 310.4 Million CNY | -17.44% |
| 2023 Q2 | 80.86 Million CNY | 14.48% |
| 2023 Q3 | 78.37 Million CNY | -3.08% |
| 2022 Q1 | 77.69 Million CNY | -28.71% |
| 2022 Q4 | 114.46 Million CNY | 15.67% |
| 2022 Q3 | 98.95 Million CNY | 16.63% |
| 2022 FY | 375.96 Million CNY | -6.76% |
| 2022 Q2 | 84.84 Million CNY | 9.2% |
| 2021 Q1 | 79.57 Million CNY | -27.82% |
| 2021 Q3 | 111.29 Million CNY | 7.66% |
| 2021 Q4 | 108.98 Million CNY | -2.07% |
| 2021 FY | 403.22 Million CNY | 10.43% |
| 2021 Q2 | 103.37 Million CNY | 29.9% |
| 2020 FY | 365.15 Million CNY | -5.07% |
| 2020 Q2 | 90.94 Million CNY | 68.04% |
| 2020 Q1 | 54.11 Million CNY | -62.97% |
| 2020 Q4 | 110.24 Million CNY | 0.36% |
| 2020 Q3 | 109.85 Million CNY | 20.79% |
| 2019 Q3 | 91.38 Million CNY | -2.14% |
| 2019 Q2 | 93.38 Million CNY | 73.74% |
| 2019 Q1 | 53.75 Million CNY | -59.61% |
| 2019 Q4 | 146.12 Million CNY | 59.91% |
| 2019 FY | 384.64 Million CNY | 11.14% |
| 2018 Q3 | 81.91 Million CNY | -1.02% |
| 2018 Q1 | 48.32 Million CNY | -54.89% |
| 2018 Q2 | 82.75 Million CNY | 71.23% |
| 2018 FY | 346.08 Million CNY | 13.63% |
| 2018 Q4 | 133.08 Million CNY | 62.47% |
| 2017 Q1 | 43.19 Million CNY | -54.74% |
| 2017 FY | 304.57 Million CNY | 10.96% |
| 2017 Q4 | 107.13 Million CNY | 39.48% |
| 2017 Q3 | 76.81 Million CNY | -0.79% |
| 2017 Q2 | 77.42 Million CNY | 79.23% |
| 2016 FY | 274.48 Million CNY | 0.09% |
| 2016 Q1 | 37.11 Million CNY | -61.88% |
| 2016 Q2 | 66.69 Million CNY | 79.7% |
| 2016 Q4 | 95.44 Million CNY | 26.88% |
| 2016 Q3 | 75.22 Million CNY | 12.78% |
| 2015 FY | 274.22 Million CNY | 4.24% |
| 2015 Q4 | 97.37 Million CNY | 59.5% |
| 2015 Q3 | 61.04 Million CNY | -8.16% |
| 2015 Q2 | 66.47 Million CNY | 34.75% |
| 2015 Q1 | 49.33 Million CNY | -41.75% |
| 2014 Q3 | 66.47 Million CNY | 5.15% |
| 2014 Q4 | 84.69 Million CNY | 27.41% |
| 2014 Q1 | 48.67 Million CNY | -20.25% |
| 2014 FY | 263.06 Million CNY | 160.04% |
| 2014 Q2 | 63.22 Million CNY | 29.88% |
| 2013 Q3 | 12.16 Million CNY | -13.08% |
| 2013 Q4 | 61.03 Million CNY | 401.6% |
| 2013 FY | 101.16 Million CNY | 63.09% |
| 2013 Q1 | 13.95 Million CNY | -33.42% |
| 2013 Q2 | 13.99 Million CNY | 0.31% |
| 2012 Q4 | 20.96 Million CNY | 65.72% |
| 2012 Q1 | 12.03 Million CNY | -15.06% |
| 2012 Q3 | 12.64 Million CNY | -22.82% |
| 2012 FY | 62.02 Million CNY | 52.47% |
| 2012 Q2 | 16.38 Million CNY | 36.22% |
| 2011 Q2 | 10.26 Million CNY | 56.8% |
| 2011 Q4 | 14.16 Million CNY | 45.93% |
| 2011 Q3 | 9.7 Million CNY | -5.47% |
| 2011 Q1 | 6.54 Million CNY | -40.77% |
| 2011 FY | 40.68 Million CNY | 10.6% |
| 2010 Q2 | 11.84 Million CNY | 69.28% |
| 2010 FY | 36.78 Million CNY | 28.66% |
| 2010 Q3 | 7 Million CNY | -40.89% |
| 2010 Q1 | 6.99 Million CNY | -16.17% |
| 2010 Q4 | 11.05 Million CNY | 57.83% |
| 2009 Q2 | 8.94 Million CNY | 68.88% |
| 2009 Q3 | 5.99 Million CNY | -33.0% |
| 2009 Q4 | 8.34 Million CNY | 39.28% |
| 2009 FY | 28.59 Million CNY | 4.51% |
| 2009 Q1 | 5.29 Million CNY | -48.03% |
| 2008 Q4 | 10.19 Million CNY | 76.78% |
| 2008 Q2 | 6.55 Million CNY | 35.43% |
| 2008 Q1 | 4.83 Million CNY | 32.12% |
| 2008 FY | 27.35 Million CNY | 79.06% |
| 2008 Q3 | 5.76 Million CNY | -12.01% |
| 2007 FY | 15.27 Million CNY | 2.75% |
| 2007 Q2 | 4.46 Million CNY | 55.63% |
| 2007 Q1 | 2.87 Million CNY | -28.2% |
| 2007 Q3 | 4.27 Million CNY | -4.4% |
| 2007 Q4 | 3.66 Million CNY | -14.28% |
| 2006 Q3 | 3.88 Million CNY | 0.0% |
| 2006 Q4 | 3.99 Million CNY | 2.85% |
| 2006 FY | 14.86 Million CNY | 10.25% |
| 2005 FY | 13.48 Million CNY | 9.96% |
| 2004 FY | 12.26 Million CNY | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Zhejiang Int'l Group Co.,Ltd. | 1.36 Billion CNY | 77.477% |
| Zhejiang Zhenyuan Share Co., Ltd. | 654.18 Million CNY | 53.04% |
| Hunan Jingfeng Pharmaceutical Co.,Ltd. | 548.76 Million CNY | 44.019% |
| Hubei Guangji Pharmaceutical Co., Ltd. | 343.25 Million CNY | 10.502% |
| Yifan Pharmaceutical Co., Ltd. | 2.82 Billion CNY | 89.14% |
| Sichuan Kelun Pharmaceutical Co., Ltd. | 7.5 Billion CNY | 95.909% |
| Chongqing Lummy Pharmaceutical Co., Ltd. | 564.68 Million CNY | 45.597% |
| Boai NKY Medical Holdings Ltd. | 309.15 Million CNY | 0.63% |
| Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. | 463.02 Million CNY | 33.653% |